Skip to content

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

Press Releases

Choose Year
Search Press Releases

Found 21 Results

November 19, 2024

LB Pharmaceuticals Names Heather Turner as CEO to Lead its Development of Transformative Advances in Schizophrenia Treatment

«1 23

IR Contact

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

All Rights Reserved.

About Us
Management
Board of Directors
Scientific Advisory Board
Careers
Contact Us

About LB-102
Pipeline
About Schizophrenia
Publications

Investors Overview
News
Events
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Investor FAQs

© 2026 LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Scroll to Top